Skip to main content
. 2015 May 11;33(18):2062–2071. doi: 10.1200/JCO.2014.59.4945

Fig 2.

Fig 2.

Multimodal screening algorithm and outcome of incidence screening. A, abnormal; CA-125, cancer antigen 125; CE, clinical evaluation; E, elevated; I, intermediate; LI, level I CA-125 test; LII, level II transvaginal scan (TVS) and CA-125 test; N, normal; ROC, risk of ovarian cancer; S, severe; SD, screening discontinued; U, unsatisfactory.